January 11, 2007

Roche Diagnostics has begun selling its next generation bench-top immunoassay analyzer, the cobas e 411 analyzer.

The device will be a big part of the company’s portfolio and is designed to be a solution for the low-to mid-volume immunoassay market.

The cobas e 411 analyzer can operate independently, as a dedicated STAT analyzer, or as part of a networked clinical laboratory environment. The unit provides results for critical assays – Troponin T, CK-MB, Myoglobin, and HCG – in as few as nine minutes. At the heart of this and all Roche Diagnostics immunoassay analyzers is electrochemiluminescence (ECL), a technology that delivers strong low-end sensitivity and a broad dynamic range.